Laws · state-regulation

South Dakota AG Says Medical Marijuana Law Meets Rescheduling

A South Dakota attorney general's legal opinion concludes the state's existing medical marijuana laws need no changes to comply with federal rescheduling, a position other states may adopt.

By Tomas Greer, State Policy ReporterPublished October 14, 20264 min read
Low angle of famous landmark with iron bell located near monumental palace against sunset sky in nature in evening time

Low angle of famous landmark with iron bell located near monumental palace against sunset sky in nature in evening time

South Dakota's attorney general concluded in a legal opinion that the state's existing medical marijuana laws already comply with federal marijuana rescheduling, MJBizDaily reported Oct. 14. If the reasoning holds, other states could skip emergency rewrites of their cannabis statutes and rules.

South Dakota Says No Rewrite Is Needed

South Dakota's attorney general concluded that the state's medical marijuana laws comply with federal rescheduling as written, according to MJBizDaily's Oct. 14, 2026 report.

MJBizDaily described the opinion as one that other states may heed. That framing matters. A state that can point to a peer's legal analysis has a ready template for telling its own regulators to stand down.

One caveat on sourcing. The MJBizDaily summary didn't include the opinion's number, its issue date, or the specific statutory provisions the attorney general reviewed. CannIntel hasn't independently reviewed the opinion text, so this report doesn't characterize its reasoning beyond the conclusion.

The stakes are practical. Attorney general opinions generally carry persuasive weight rather than binding force in court, but regulators tend to follow them, and a finding of compliance means no emergency rulemaking, no special legislative session and no pause in patient access while lawmakers sort out definitions.

Why States Have to Ask the Question

Marijuana sits in Schedule I under 21 U.S.C. § 812, so any DEA move to a lower schedule forces states to check every place their codes borrow federal language.

Most state programs are built on their own definitions and licensing schemes. Many still touch federal law at the edges. Typical pressure points include:

  • Definitions of marijuana or cannabis that cross-reference the federal Controlled Substances Act.
  • Practitioner certification rules that mirror federal prescribing or registration concepts.
  • Product-testing and labeling standards written with federal schedules in mind.
  • Criminal-code provisions that key penalties to a drug's federal schedule.

Not every state has these hooks. Some have several. A statute that says "as defined in federal law" is the kind of phrase that prompts a legal review after a rescheduling.

That's the review South Dakota's attorney general apparently completed. The state's medical program traces to voter-approved Initiated Measure 26 in 2020.

What the Opinion Does Not Settle

A state attorney general opinion answers a state-law question and leaves federal law, including tax treatment under 280E, untouched.

Three limits are worth keeping straight.

  1. It isn't a federal ruling. The DEA's rulemaking and any final schedule placement are separate from how a state reads its own statutes.
  2. It doesn't create a federal pathway for state dispensaries. Rescheduling alone doesn't turn state-licensed sales into federally sanctioned commerce.
  3. It doesn't address tax. Section 280E of the Internal Revenue Code denies deductions to businesses trafficking in Schedule I and II substances. That's a federal tax matter for the IRS and Congress, not for state attorneys general.

Still, the instinct is sound. A program built on its own definitions shouldn't break because Washington relabels the plant.

Compliance and benefit are different things. A state can pass the first test and still see operators wait on the second.

What Operators and Other States Should Watch

The next tell is whether other attorneys general and health departments issue comparable opinions or guidance.

States that wrote their cannabis laws with explicit federal cross-references have the most to check, while those with self-contained definitions can likely follow South Dakota's lead faster. Operators in either group should ask their regulators in writing whether a compliance review is underway.

Watch for these developments:

  • Similar legal opinions from other state attorneys general.
  • Guidance from state health or cannabis regulators on how federal schedule changes affect existing rules.
  • Any language in the DEA's rulemaking record that addresses state programs directly.

For full background on the federal process behind all of this, see the CannIntel topic hub on DEA marijuana rescheduling.

The next signal: whether a second state publishes its own compliance analysis before legislatures reconvene. South Dakota went first, and the others are now on the clock.

Full context

For complete background, history, and our ongoing coverage of this story:

Open the CannIntel topic hub →

Frequently asked questions

What did South Dakota's attorney general conclude about rescheduling?

According to MJBizDaily, the attorney general's legal opinion found that South Dakota's existing medical marijuana laws comply with federal marijuana rescheduling. The opinion indicates the state doesn't need to change its rules to stay compliant. The opinion's full text wasn't reviewed for this report.

Does the opinion change federal marijuana law?

No. An attorney general opinion interprets state law. Marijuana's federal status under 21 U.S.C. § 812 and any DEA rulemaking are separate processes, and the opinion doesn't alter either.

Will other states have to follow South Dakota's approach?

No. The opinion isn't binding on other states. MJBizDaily said other states may heed it, but each state's compliance depends on how its own statutes define marijuana and whether they cross-reference federal schedules.

Does rescheduling affect 280E tax treatment?

Section 280E of the Internal Revenue Code applies to Schedule I and II substances. That's a federal tax question outside the scope of a state attorney general's opinion on state-law compliance.

Sources

DEA reschedulingSouth Dakota medical marijuanastate attorney general opinion21 U.S.C. § 812state cannabis regulation
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Laws

More from the newsroom